Sensei Biotherapeutics Inc
Research Sensei Biotherapeutics Inc (SNSE) on Bullrun: market cap USD 28.85M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSNSE
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 28.85M
- Financial periodQ1 2026
- RevenueUSD 0
- Net income-USD 184.46M
- Free cash flow-USD 24.11M
Valuation Snapshot
latest market cap is USD 28.85M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 21.09M | -USD 20.47M | n/a | -16.72 | USD 8.67M | USD 1.51M | USD 18.59M |
| FY2024 | USD 0 | -USD 30.16M | -USD 24.82M | n/a | -24.01 | USD 9.99M | USD 3.85M | USD 38.39M |
| FY2023 | USD 0 | -USD 34.10M | -USD 32.20M | n/a | -1.22 | USD 13.01M | USD 6.21M | USD 64.90M |
| FY2022 | USD 0 | -USD 48.59M | -USD 39.35M | n/a | -1.58 | USD 17.80M | USD 8.03M | USD 103.41M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-06-26 | USD 28.85M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 13.45M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 12.34M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 17.30M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 45.77M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 177.54M | n/a | n/a | n/a |
About Sensei Biotherapeutics Inc
Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. It offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Sensei Biotherapeutics Inc's market cap?
Sensei Biotherapeutics Inc's market capitalization is USD 28.85M.
What does Sensei Biotherapeutics Inc do?
Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. It offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors.